Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study.
Haraoui B, Khraishi M, Choquette D, Fortin I, Kinch CD, Galos C, Roy P, Gruben D, Vaillancourt J, Sampalis JS, Keystone EC. Haraoui B, et al. Among authors: choquette d. Rheumatol Ther. 2024 Dec;11(6):1629-1648. doi: 10.1007/s40744-024-00719-5. Epub 2024 Nov 1. Rheumatol Ther. 2024. PMID: 39485671 Free PMC article.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, Galos C, Roy P, Gruben D, Woolcott JC, Vaillancourt J, Sampalis JS, Keystone EC; Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators. Haraoui B, et al. Among authors: choquette d. Arthritis Care Res (Hoboken). 2023 Feb;75(2):240-251. doi: 10.1002/acr.24966. Epub 2022 Oct 10. Arthritis Care Res (Hoboken). 2023. PMID: 35678771 Free PMC article.
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.
Rahman P, Baer P, Keystone E, Choquette D, Thorne C, Haraoui B, Chow A, Faraawi R, Olszynski W, Kelsall J, Rampakakis E, Lehman AJ, Nantel F. Rahman P, et al. Among authors: choquette d. BMC Rheumatol. 2020 Sep 19;4:46. doi: 10.1186/s41927-020-00145-4. eCollection 2020. BMC Rheumatol. 2020. PMID: 32968710 Free PMC article.
Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.
Thorne C, Bensen WG, Choquette D, Chow A, Khraishi M, Atkins CJ, Kelsall JT, Lehman AJ, Shawi M, Khalil H, Nantel F, Rampakakis E, Sampalis JS, Otawa S. Thorne C, et al. Among authors: choquette d. Arthritis Care Res (Hoboken). 2014 Aug;66(8):1142-51. doi: 10.1002/acr.22290. Arthritis Care Res (Hoboken). 2014. PMID: 24470077 Free article.
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.
Rahman P, Choquette D, Bensen WG, Khraishi M, Chow A, Zummer M, Shaikh S, Sheriff M, Dixit S, Sholter D, Psaradellis E, Sampalis JS, Letourneau V, Lehman AJ, Nantel F, Rampakakis E, Otawa S, Shawi M. Rahman P, et al. Among authors: choquette d. BMJ Open. 2016 Apr 5;6(4):e009661. doi: 10.1136/bmjopen-2015-009661. BMJ Open. 2016. PMID: 27048632 Free PMC article. Clinical Trial.
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.
Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH; OBRI, RHUMADATA, CATCH Investigators, and the Rheum4U Team. Hazlewood GS, et al. Among authors: choquette d. J Rheumatol. 2022 Jan;49(1):16-25. doi: 10.3899/jrheum.201688. Epub 2021 Aug 1. J Rheumatol. 2022. PMID: 34334357
Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA.
Choquette D, Haraoui B, Movahedi M, Bessette L, Sauvageau LC, Ferdinand I, Joly-Chevrier M, Masetto A, Massicotte F, Nadon V, Pelletier JP, Raynauld JP, Sauvageau D, Villeneuve É, Coupal L. Choquette D, et al. Rheumatology (Oxford). 2024 Jun 3:keae283. doi: 10.1093/rheumatology/keae283. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38830031
103 results